A multi-organ, feto-maternal interface organ-on-chip, models pregnancy pathology and is a useful preclinical extracellular vesicle drug trial platform.
EVs
Fetal membrane
Interleukin-10
Microphysiological systems
Placenta
preterm birth
Journal
Extracellular vesicle
ISSN: 2773-0417
Titre abrégé: Extracell Vesicle
Pays: United States
ID NLM: 9918487587406676
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
medline:
14
6
2024
pubmed:
14
6
2024
entrez:
14
6
2024
Statut:
ppublish
Résumé
Pregnant women and their fetuses are often excluded from clinical trials due to missing drug-related pre-clinical trial information at the human feto-maternal interface (FMi). The two interfaces-placenta/decidua and fetal membranes/decidua are gatekeepers of drug transport; however, testing their functions is impractical during pregnancy. Limitations of current
Identifiants
pubmed: 38872854
doi: 10.1016/j.vesic.2024.100035
pmc: PMC11175617
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
Statements and Declarations: The authors declare no conflicts of interest.